1381 - 1390 of 7785 Results
Title
Year
-
RESTRICTEDTitle: Who to Enroll in Parkinson Disease Prevention Trials?Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 7_Supplement_1Start Page: 10End Page: 18Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200812Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/10.full.pdfCitation Count: 8
- Measurement Properties of Clinical Scales Rating the Severity of Blepharospasm: A Multicenter Observational Study2022RESTRICTEDTitle: Measurement Properties of Clinical Scales Rating the Severity of Blepharospasm: A Multicenter Observational StudyJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 7Start Page: 949End Page: 955Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13530Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547140Citation Count: 5
- Vestibular Sensory Conflict During Postural Control, Freezing of Gait, and Falls in Parkinson's Disease2022RESTRICTEDTitle: Vestibular Sensory Conflict During Postural Control, Freezing of Gait, and Falls in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 11Start Page: 2257End Page: 2262Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29189Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29189Citation Count: 11
- Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson disease2022RESTRICTEDTitle: Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson diseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.971252Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.971252/pdfCitation Count: 8
- Serum MicroRNAs Predict Isolated Rapid Eye Movement Sleep Behavior Disorder and Lewy Body Diseases2022RESTRICTEDTitle: Serum MicroRNAs Predict Isolated Rapid Eye Movement Sleep Behavior Disorder and Lewy Body DiseasesJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 10Start Page: 2086End Page: 2098Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29171Best OA location URL: https://doi.org/10.1002/mds.29171Citation Count: 9
-
RESTRICTEDTitle: Aberrant splicing of PSEN2, but not PSEN1, in individuals with sporadic Alzheimer’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 2Start Page: 507End Page: 518Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/brain/awac294Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169283Citation Count: 7
- Longitudinal Mediating Effect of Depression on the Relationship between Excessive Daytime Sleepiness and Activities of Daily Living in Parkinson’s Disease2022RESTRICTEDTitle: Longitudinal Mediating Effect of Depression on the Relationship between Excessive Daytime Sleepiness and Activities of Daily Living in Parkinson’s DiseaseJournal Name: Clinical GerontologistPublisher: Informa UK LimitedVol: 47Issue #: 3Start Page: 426End Page: 435Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/07317115.2022.2111014Citation Count: 4
- Management of dysphagia and gastroparesis in Parkinson’s disease in real-world clinical practice – Balancing pharmacological and non-pharmacological approaches2022RESTRICTEDTitle: Management of dysphagia and gastroparesis in Parkinson’s disease in real-world clinical practice – Balancing pharmacological and non-pharmacological approachesJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.979826Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.979826/pdfCitation Count: 8
- Structural Insights and Development of LRRK2 Inhibitors for Parkinson’s Disease in the Last Decade2022RESTRICTEDTitle: Structural Insights and Development of LRRK2 Inhibitors for Parkinson’s Disease in the Last DecadeJournal Name: GenesPublisher: MDPI AGVol: 13Issue #: 8Start Page: 1426End Page: 1426Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/genes13081426Best OA location URL: https://www.mdpi.com/2073-4425/13/8/1426/pdf?version=1660204965Citation Count: 5
- Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson’s disease patients2022RESTRICTEDTitle: Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson’s disease patientsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00366-zBest OA location URL: https://www.nature.com/articles/s41531-022-00366-z.pdfCitation Count: 28